Radiofrequency ablation (RFA) is a proven, minimally invasive interventional radiology procedure that uses radiofrequency electrical energy to generate heat and destroy tumors and abnormal tissues with pinpoint precision. Since its introduction in the 1990s, RFA has become a well-established, evidence-backed treatment for liver tumors, kidney tumors, lung tumors, bone tumors, varicose veins, cardiac arrhythmias, and thyroid nodules. At Edge Imaging and Diagnostics, Raghubir Nagar, West Delhi, our specialist interventional radiologists perform RFA using image guidance for patients across the region — including those from Rajouri Garden, Tagore Garden, Punjabi Bagh, Paschim Vihar, Moti Nagar, Kirti Nagar, and Janakpuri.

This comprehensive guide explains how RFA works, its applications, how it compares to microwave ablation, preparation, procedure details, recovery, and costs in Delhi.

What Is Radiofrequency Ablation (RFA)? The Science Explained

Radiofrequency ablation (RFA) uses alternating radiofrequency electrical current (typically 375–500 kHz) delivered through a specialized RFA electrode needle placed directly into the target tissue. The radiofrequency current causes ionic agitation in the tissue surrounding the electrode tip, generating frictional heat that raises the local temperature to 60–100°C. At temperatures above 60°C, cellular proteins denature and cells undergo coagulative necrosis — the tissue equivalent of being cooked.

The RFA electrode creates a precisely controlled zone of thermal destruction — the “ablation zone” — typically 2–4 cm in diameter per application. Multiple overlapping applications, or expandable multi-tine electrodes, allow treatment of larger tumors. The surrounding liver, kidney, or other normal organ tissue is partially protected from thermal damage by the natural cooling effect of blood flow in nearby vessels.

RFA is supported by decades of clinical evidence and international guidelines from the European Association for the Study of the Liver (EASL), the American Association for the Study of Liver Disease (AASLD), and the WHO for the treatment of early-stage hepatocellular carcinoma (HCC).

RFA Indications — What Conditions Are Treated at Edge Imaging and Diagnostics?

RFA for Liver Tumors (Hepatocellular Carcinoma and Metastases)

RFA of the liver is the most extensively studied and widely performed ablation procedure globally. Key indications include:

Early-stage HCC (hepatocellular carcinoma): Single tumor ≤3 cm (or up to 3 tumors ≤3 cm each) in patients with cirrhosis who are not surgical candidates or who prefer non-surgical treatment. RFA achieves complete ablation in 80–95% of tumors ≤3 cm and provides median survival comparable to surgical resection in BCLC stage 0/A patients
Colorectal liver metastases: Unresectable or limited liver metastases from colorectal cancer — RFA significantly improves overall survival when combined with systemic chemotherapy
Liver metastases from neuroendocrine tumors: RFA effectively controls metastatic carcinoid and neuroendocrine tumor deposits, reducing hormonal symptoms
Recurrent HCC after prior resection or transarterial chemoembolization (TACE)

RFA for Kidney Tumors (Renal Cell Carcinoma)

Percutaneous CT-guided RFA of small renal cell carcinoma (RCC) is an established, guideline-recommended treatment option for:

Elderly patients or those with significant comorbidities who cannot tolerate partial nephrectomy
Patients with solitary kidney (hereditary or post-surgical) requiring nephron-sparing treatment
Patients with hereditary RCC syndromes (Von Hippel-Lindau, Birt-Hogg-Dubé) with multiple bilateral tumors
Renal tumors ≤4 cm not involving the collecting system

RFA for Lung Tumors

CT-guided RFA of lung tumors is used for inoperable early-stage NSCLC (non-small cell lung cancer) and limited pulmonary metastases. It is particularly valuable for patients with severe pulmonary compromise who cannot tolerate surgical resection. Success rates (complete ablation) for tumors ≤3 cm range from 70–85%.

RFA for Bone Tumors (Osteoid Osteoma)

CT-guided RFA is the gold standard treatment for osteoid osteoma — a benign but extremely painful bone tumor, most common in adolescents and young adults. The characteristic severe nocturnal pain responds dramatically to salicylates but recurs without definitive treatment. CT-guided RFA destroys the nidus (the pain-generating center of the tumor) with pain relief rates exceeding 95% in a single outpatient procedure. This has completely replaced the need for surgical resection of osteoid osteoma in experienced centers.

RFA for Thyroid Nodules

Ultrasound-guided RFA of thyroid nodules is an effective alternative to surgery for:

Benign symptomatic thyroid nodules causing compression symptoms or cosmetic concerns
Autonomously functioning thyroid nodules (toxic adenoma) causing hyperthyroidism
Low-risk papillary thyroid microcarcinomas in selected patients
Recurrent thyroid cancer nodules in the thyroid bed not amenable to re-operation

Other RFA Applications

Varicose vein treatment (Endovenous RFA / EVLA): Minimally invasive thermal ablation of the great saphenous vein for varicose veins and chronic venous insufficiency — replacing traditional surgical vein stripping
Cardiac arrhythmia RFA: Cardiac electrophysiology-guided RFA for atrial fibrillation, SVT, and accessory pathway ablation — performed by cardiac electrophysiologists using catheter-based techniques
Pain management: Facet joint RFA, genicular nerve RFA for knee osteoarthritis, and sacroiliac joint RFA for chronic back pain
Adrenal tumor RFA

RFA vs. Microwave Ablation vs. Surgery — Choosing the Right Treatment

Parameter	RFA	Microwave Ablation (MWA)	Surgical Resection
Invasiveness	Minimally invasive (needle through skin)	Minimally invasive (needle through skin)	Major surgery — large incision
Anaesthesia	Local + conscious sedation or GA	Local + conscious sedation or GA	General anaesthesia always required
Hospital stay	1–3 days	1–3 days	5–14 days
Best tumor size	≤3 cm (optimal); ≤5 cm (acceptable)	≤5 cm (often better than RFA for larger tumors)	Any resectable size
Perivascular tumors	Suboptimal (heat sink effect)	Better than RFA	Good
Multiple tumors	Up to 3–5 in single session	Up to 3–5 in single session	Dependent on liver reserve
Mortality risk	<0.5%	<0.5%	1–5% (hepatectomy)
Evidence base	Extensive — 20+ years of RCT data	Growing — newer but compelling	Gold standard for resectable disease

The RFA Procedure at Edge Imaging and Diagnostics, Raghubir Nagar

Pre-Procedure Assessment and Planning

Before RFA, our interventional radiologist reviews all available imaging (contrast CT, MRI, or PET-CT) to precisely characterize the target tumor — its size, location, relationship to hepatic vessels, bile ducts, and adjacent organs. Tumor histology (biopsy result) is confirmed. A multidisciplinary tumor board discussion ensures that RFA is the optimal treatment modality.

Electrode Placement Under Image Guidance

Under ultrasound or CT guidance, the RFA electrode is introduced through the skin and into the center of the target tumor. For ultrasound-guided RFA (most liver and thyroid cases), real-time needle tip visualization guides precise placement. For CT-guided RFA (deep abdominal, renal, bone, or lung tumors), the “advance-scan-verify” technique ensures the electrode tip is correctly positioned before energy delivery.

Energy Delivery and Monitoring

Energy is delivered for 10–30 minutes per ablation cycle (longer than MWA). Tissue temperature and impedance are monitored in real time by the RFA generator. As tissue around the electrode heats up and desiccates, impedance rises — the generator automatically adjusts power delivery. Grounding pads are applied to the patient’s thighs to complete the electrical circuit. Multiple overlapping ablations are performed for larger tumors.

Post-Ablation Imaging

After RFA, contrast-enhanced CT or ultrasound confirms the ablation zone — a non-enhancing (dark) area encompassing the entire tumor with an adequate safety margin. The absence of contrast enhancement within the treated area confirms successful coagulative necrosis.

Preparing for RFA in Delhi — Pre-Procedure Checklist

Fasting: Nothing by mouth for 6 hours before (4 hours for clear fluids)
Blood tests: CBC, PT-INR (≤1.5 required), LFT, KFT within 2 weeks
Imaging: Bring latest contrast CT or MRI showing the target lesion
Blood thinners: Warfarin stopped 5–7 days; aspirin/clopidogrel stopped 5 days; NOACs 24–48 hours before the procedure
Antibiotic prophylaxis: Given before liver RFA to reduce infection risk
Hospital admission: Plan for 24–48 hour observation post-procedure for liver/kidney/lung RFA; bone RFA (osteoid osteoma) and thyroid RFA are typically day procedures

Post-RFA Recovery and Care

Post-ablation syndrome: Expected and normal — low-grade fever, fatigue, and mild procedure-site pain for 1–7 days; managed with paracetamol and NSAIDs
Activity restriction: Avoid strenuous physical activity for 1–2 weeks after liver or renal RFA
Diet: Light diet for 48 hours; resume normal diet as tolerated
Follow-up imaging: Contrast CT or MRI at 1 month post-RFA to assess ablation completeness; then at 3, 6, 12 months for surveillance
Tumor markers: Serial AFP (for HCC), CEA (for colorectal metastases) at follow-up visits

RFA Costs in Delhi — Pricing Guide

RFA Application	Approximate Cost (INR)
Liver RFA (HCC or metastasis)	₹40,000 – ₹90,000 per session
Renal (Kidney) RFA	₹35,000 – ₹80,000
Lung RFA	₹40,000 – ₹85,000
Osteoid Osteoma (Bone) RFA	₹25,000 – ₹50,000
Thyroid Nodule RFA	₹25,000 – ₹55,000
Adrenal RFA	₹35,000 – ₹75,000

Costs include the RFA procedure, imaging guidance, consumables, and standard post-procedure monitoring. Hospital admission and anaesthesia charges may be additional. Please contact Edge Imaging and Diagnostics, Raghubir Nagar, for an individualized cost estimate.

Suggested Images

Image 1 Alt Text: “Radiofrequency ablation RFA of liver tumor being performed at Edge Imaging Diagnostics Delhi”
Image 2 Alt Text: “RFA electrode positioned in HCC liver tumor under ultrasound guidance at Raghubir Nagar Delhi”
Image 3 Alt Text: “CT scan showing complete ablation zone after RFA liver cancer treatment Delhi”
Image 4 Alt Text: “RFA radiofrequency ablation center near Punjabi Bagh Rajouri Garden West Delhi”

Frequently Asked Questions — RFA in Delhi

Q1. Is RFA better than microwave ablation for liver cancer?

Both RFA and MWA achieve excellent results for small liver tumors (≤3 cm). RFA has a longer evidence base (20+ years of studies), while MWA offers faster ablation, larger ablation zones, and better performance for perivascular tumors or those adjacent to large blood vessels where the “heat sink” effect limits RFA. For tumors >3–4 cm or in challenging locations (near hepatic veins, portal vein), MWA may be preferred. Our team individually selects the optimal ablation modality for each patient’s tumor characteristics.

Q2. How many sessions of RFA are needed for liver cancer?

Most small (≤3 cm) HCC tumors can be completely ablated in a single RFA session. For larger tumors or multiple tumors, 2–3 sessions may be planned over several weeks. Recurrent tumors after initial RFA can often be re-treated with repeat ablation. Each case is individualized, and our multidisciplinary team will outline the planned treatment course at your consultation.

Q3. What is osteoid osteoma and why is RFA the preferred treatment?

Osteoid osteoma is a small, benign bone tumor most commonly affecting the femur, tibia, and spine, typically in adolescents and young adults. Its hallmark is severe nocturnal bone pain that is dramatically relieved by aspirin/NSAIDs. CT-guided RFA destroys the pain-generating nidus of the tumor in a single outpatient procedure with >95% success rate — achieving permanent cure without the morbidity, hospitalization, and rehabilitation of surgical resection. It is the procedure of choice at Edge Imaging and Diagnostics, Raghubir Nagar, for this condition.

Q4. Can RFA be repeated if the tumor comes back?

Yes. A significant advantage of ablation over surgery is the ability to repeat treatment. Local recurrence after RFA (typically detected on follow-up imaging at 1–3 months) can often be retreated with repeat RFA, microwave ablation, or TACE (transarterial chemoembolization), depending on the lesion characteristics and patient status. This flexibility makes ablation an ongoing management strategy rather than a one-time intervention.

Q5. Where can I get RFA for liver cancer near Rajouri Garden or Janakpuri?

Edge Imaging and Diagnostics in Raghubir Nagar is Delhi’s leading interventional radiology center for RFA and microwave ablation of liver, kidney, lung, and bone tumors. Our center is approximately 3–5 km from Rajouri Garden and within 7 km of Tagore Garden, Punjabi Bagh, Kirti Nagar, Moti Nagar, Paschim Vihar, and Janakpuri — making it the most convenient choice for patients from West Delhi seeking advanced tumor ablation.

Book Your RFA Consultation at Edge Imaging and Diagnostics, Delhi

Radiofrequency ablation (RFA) at Edge Imaging and Diagnostics, Raghubir Nagar offers eligible patients a minimally invasive, scientifically proven pathway to effective tumor control — without the risks, hospital stay, and prolonged recovery of major surgery. Our expert interventional radiology team brings decades of experience in ablation therapy to every case.

📞 Call us to schedule your RFA consultation in Delhi.
📍 Visit Edge Imaging and Diagnostics, Raghubir Nagar, New Delhi.
🌐 Book online at our portal.

RFA in Delhi: Radiofrequency Ablation for Tumors — Procedure, Cost & Recovery Guide